Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study to Evaluate Pharmacokinetics and Safety of AmBisome and DKF-5122 in Indicated Patients and Healthy Adults

NCT05749380 is registered in ClinicalTrials.gov with Dongkook Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05749380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05749380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study to Evaluate Pharmacokinetics and Safety of AmBisome and DKF-5122 in Indicated Patients and Healthy Adults
Lead sponsor
Dongkook Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
September 7, 2020
Completion date
January 28, 2022
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive fungal infections, neutropenic fever